New hope for stomach and bowel cancers? experimental drug enters human trials
NCT ID NCT06885034
First seen Jun 26, 2026 · Last updated Aug 04, 2026 · Updated 5 times
Summary
This study tests an experimental drug called GSK5764227, given alone or with other treatments, in 320 people with advanced gastrointestinal cancers that have not responded to prior therapy. The main goal is to see if the drug can shrink tumors and how safe it is. It is an early-stage trial, so results will help determine if larger studies are warranted.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- GSK5764227 (an experimental biologic drug)
- What this could lead to
- If successful, this could point toward a new treatment option for people with advanced gastrointestinal cancers that have stopped responding to prior therapies.
- What could go wrong
- This is an early-phase trial (Phase 1/2) with a small number of participants, so the drug may not work as hoped or could have unexpected side effects. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
GSK Investigational Site
RECRUITINGLos Alamitos, California, 90505, United States
-
GSK Investigational Site
RECRUITINGLos Angeles, California, 90089, United States
-
GSK Investigational Site
RECRUITINGSanta Monica, California, 90404, United States
-
GSK Investigational Site
RECRUITINGWhittier, California, 90602, United States
-
GSK Investigational Site
RECRUITINGAurora, Colorado, 80045, United States
-
GSK Investigational Site
RECRUITINGNew York, New York, 10021, United States
-
GSK Investigational Site
RECRUITINGNew York, New York, 10065, United States
-
GSK Investigational Site
RECRUITINGDurham, North Carolina, 27710, United States
-
GSK Investigational Site
RECRUITINGHouston, Texas, 77479, United States
-
GSK Investigational Site
RECRUITINGSan Antonio, Texas, 78229, United States
-
GSK Investigational Site
RECRUITINGWenatchee, Washington, 98801, United States
-
GSK Investigational Site
RECRUITINGMadison, Wisconsin, 53792-0001, United States
-
GSK Investigational Site
RECRUITINGHeidelberg, Victoria, 3084, Australia
-
GSK Investigational Site
RECRUITINGMelbourne, Victoria, 3000, Australia
-
GSK Investigational Site
RECRUITINGBonheiden, 2820, Belgium
-
GSK Investigational Site
RECRUITINGBrussels, 1200, Belgium
-
GSK Investigational Site
RECRUITINGLeuven, 3000, Belgium
-
GSK Investigational Site
RECRUITINGRoeselare, 8800, Belgium
-
GSK Investigational Site
RECRUITINGPorto Alegre, 90850-170, Brazil
-
GSK Investigational Site
RECRUITINGSão Paulo, 01246-000, Brazil
-
GSK Investigational Site
RECRUITINGTeresina, 64049-200, Brazil
-
GSK Investigational Site
RECRUITINGCalgary, Alberta, T2N 5G2, Canada
-
GSK Investigational Site
RECRUITINGToronto, Ontario, M5G 2M9, Canada
-
GSK Investigational Site
RECRUITINGMontreal, Quebec, H2X 0C1, Canada
-
GSK Investigational Site
RECRUITINGSherbrooke, Quebec, J1H 5N4, Canada
-
GSK Investigational Site
RECRUITINGHelsinki, 00029, Finland
-
GSK Investigational Site
RECRUITINGHelsinki, 00180, Finland
-
GSK Investigational Site
RECRUITINGKuopio, 70210, Finland
-
GSK Investigational Site
RECRUITINGTampere, 33520, Finland
-
GSK Investigational Site
RECRUITINGDijon, 21079, France
-
GSK Investigational Site
RECRUITINGMarseille, 13273, France
-
GSK Investigational Site
RECRUITINGParis, 75010, France
-
GSK Investigational Site
RECRUITINGParis, 75012, France
-
GSK Investigational Site
RECRUITINGParis, 75015, France
-
GSK Investigational Site
RECRUITINGPoitiers, 86021, France
-
GSK Investigational Site
RECRUITINGRennes, 35042, France
-
GSK Investigational Site
RECRUITINGVillejuif, 94805, France
-
GSK Investigational Site
RECRUITINGBochum, 44791, Germany
-
GSK Investigational Site
RECRUITINGDüsseldorf, 40225, Germany
-
GSK Investigational Site
RECRUITINGFrankfurt, 60488, Germany
-
GSK Investigational Site
RECRUITINGLübeck, 23562, Germany
-
GSK Investigational Site
RECRUITINGMünchen, 81737, Germany
-
GSK Investigational Site
RECRUITINGMilan, 20133, Italy
-
GSK Investigational Site
RECRUITINGMilan, 20162, Italy
-
GSK Investigational Site
RECRUITINGPisa, 56126, Italy
-
GSK Investigational Site
RECRUITINGRoma, 00168, Italy
-
GSK Investigational Site
RECRUITINGAichi, 464-8681, Japan
-
GSK Investigational Site
RECRUITINGChiba, 277-8577, Japan
-
GSK Investigational Site
RECRUITINGHokkaido, 060-8648, Japan
-
GSK Investigational Site
RECRUITINGOsaka, 565-0871, Japan
-
GSK Investigational Site
RECRUITINGTokyo, 104-0045, Japan
-
GSK Investigational Site
RECRUITINGTokyo, 135-8550, Japan
-
GSK Investigational Site
RECRUITINGTuxtla Gutiérrez, Chiapas, 29090, Mexico
-
GSK Investigational Site
RECRUITINGCuernavaca, Morelos, 62448, Mexico
-
GSK Investigational Site
RECRUITINGMexico City, 03100, Mexico
-
GSK Investigational Site
RECRUITINGMexico City, 06100, Mexico
-
GSK Investigational Site
RECRUITINGSan Pedro Garza García, 66260, Mexico
-
GSK Investigational Site
RECRUITINGAmsterdam, 1066 CX, Netherlands
-
GSK Investigational Site
RECRUITINGMaastricht, 6229 HX, Netherlands
-
GSK Investigational Site
RECRUITINGRotterdam, 3015 GD, Netherlands
-
GSK Investigational Site
RECRUITINGUtrecht, 3584 CX, Netherlands
-
GSK Investigational Site
RECRUITINGLrenskog, 1474, Norway
-
GSK Investigational Site
RECRUITINGOslo, 0407, Norway
-
GSK Investigational Site
RECRUITINGStavanger, 4011, Norway
-
GSK Investigational Site
RECRUITINGLa Villa de Los Santos, Los Santos Province, 6040, Panama
-
GSK Investigational Site
RECRUITINGPunta Pacifica Panama City Panama, Panama
-
GSK Investigational Site
RECRUITINGBrzozów, 36-200, Poland
-
GSK Investigational Site
RECRUITINGKoszalin, 75-581, Poland
-
GSK Investigational Site
RECRUITINGWarsaw, 02-034, Poland
-
GSK Investigational Site
RECRUITINGSeoul, Seoul Teugbyeolsi, 110 744, South Korea
-
GSK Investigational Site
RECRUITINGSeoul, 135-710, South Korea
-
GSK Investigational Site
RECRUITINGSeoul, 138-736, South Korea
-
GSK Investigational Site
RECRUITINGBarcelona, 08041, Spain
-
GSK Investigational Site
RECRUITINGHebrOn, 08035, Spain
-
GSK Investigational Site
RECRUITINGMadrid, 28007, Spain
-
GSK Investigational Site
RECRUITINGMadrid, 28034, Spain
-
GSK Investigational Site
RECRUITINGMadrid, 28041, Spain
-
GSK Investigational Site
RECRUITINGPamplona, 31008, Spain
-
GSK Investigational Site
RECRUITINGSantander, 39011, Spain
-
GSK Investigational Site
RECRUITINGZaragoza, 50009, Spain
-
GSK Investigational Site
RECRUITINGGothenburg, SE-413 45, Sweden
-
GSK Investigational Site
RECRUITINGLund, 22185, Sweden
-
GSK Investigational Site
RECRUITINGStockholm, SE-118 83, Sweden
-
GSK Investigational Site
RECRUITINGUppsala, 751 85, Sweden
-
GSK Investigational Site
RECRUITINGManchester, M20 4BX, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo shrink Hard-to-Treat tumors?
- Can a pill rouse the immune system against pancreatic cancer?
- A sound wave that could expose hidden pancreatic cancer?
- Can a new immunotherapy combo shrink Hard-to-Treat tumors?
- Can a Two-Target antibody shrink Hard-to-Treat cancers?
- Can a disposable device improve endoscopic tissue closure?